Bendamustine in the treatment of multiple myeloma:: Results and future perspectives

被引：18
|
作者：
Pönisch, W
Niederwieser, D
机构：
[1] Univ Leipzig, Div Hematol & Oncol, D-4103 Leipzig, Germany
[2] Univ Leipzig, E German Study Grp Hematol & Oncol, D-4103 Leipzig, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 04期
关键词：
D O I：
10.1016/S0093-7754(02)90011-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [41] Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
    Davies, Faith E.
    Pawlyn, Charlotte
    Usmani, Saad Z.
    San-Miguel, Jesus F.
    Einsele, Hermann
    Boyle, Eileen M.
    Corre, Jill
    Auclair, Daniel
    Cho, Hearn Jay
    Lonial, Sagar
    Sonneveld, Pieter
    Stewart, A. Keith
    Bergsagel, P. Leif
    Kaiser, Martin F.
    Weisel, Katja
    Keats, Jonathan J.
    Mikhael, Joseph R.
    Morgan, Kathryn E.
    Ghobrial, Irene M.
    Orlowski, Robert Z.
    Landgren, C. Ola
    Gay, Francesca
    Caers, Joseph
    Chng, Wee Joo
    Chari, Ajai
    Walker, Brian A.
    Kumar, Shaji K.
    Costa, Luciano J.
    Anderson, Kenneth C.
    Morgan, Gareth J.
    BLOOD CANCER DISCOVERY, 2022, 3 (07): : 273 - 284
  • [42] EVOLUTION AND PRESENT PERSPECTIVES OF THE TREATMENT OF MULTIPLE-MYELOMA
    MARCA, AS
    ALVAREZ, JL
    MASSIEU, FJA
    REVISTA CLINICA ESPANOLA, 1983, 171 (03): : 225 - 229
  • [43] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Dharshan Sivaraj
    Michael M Green
    Yubin Kang
    Gwynn D Long
    David A Rizzieri
    Zhiguo Li
    Anderson H Garrett
    Jackie L McIntyre
    Nelson J Chao
    Cristina Gasparetto
    Blood Cancer Journal, 8
  • [44] BENDAMUSTINE : A NEW OPTION FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Madonna, E.
    Marano, L.
    Pugliese, N.
    Avilia, S.
    Cerciello, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2013, 98 : 612 - 612
  • [45] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [46] BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA
    Villa, M. R.
    Gagliardi, A.
    Della Cioppa, P.
    Esposito, M.
    Lucania, A.
    Izzo, G. Nitrato
    Improta, S.
    Mastrullo, L.
    HAEMATOLOGICA, 2016, 101 : S114 - S114
  • [47] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Kang, Yubin
    Long, Gwynn D.
    Rizzieri, David A.
    Li, Zhiguo
    Garrett, Anderson H.
    McIntyre, Jackie L.
    Chao, Nelson J.
    Gasparetto, Cristina
    BLOOD CANCER JOURNAL, 2018, 8
  • [48] Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party
    Lee, Jae Hoon
    Lee, Dong Soon
    Lee, Je Jung
    Chang, Yoon Hwan
    Jin, Jong Youl
    Jo, Deog-Yeon
    Bang, Soo Mee
    Kim, Hyo Jung
    Kim, Jin Seok
    Kim, Kihyun
    Eom, Hyeon Seok
    Min, Chang Ki
    Yoon, Sung Soo
    Kim, Sun Hee
    Suh, Cheolwon
    Cho, Kyung Sam
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 52 - 57
  • [49] Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party
    Jae Hoon Lee
    Dong Soon Lee
    Je Jung Lee
    Yoon Hwan Chang
    Jong Youl Jin
    Deog-Yeon Jo
    Soo Mee Bang
    Hyo Jung Kim
    Jin Seok Kim
    Kihyun Kim
    Hyeon Seok Eom
    Chang Ki Min
    Sung Soo Yoon
    Sun Hee Kim
    Cheolwon Suh
    Kyung Sam Cho
    International Journal of Hematology, 2010, 92 : 52 - 57
  • [50] Panobinostat: a review of trial results and future prospects in multiple myeloma
    Libby, Edward N.
    Becker, Pamela S.
    Burwick, Nicholas
    Green, Damian J.
    Holmberg, Leona
    Bensinger, William Ira
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (01) : 9 - 18
12345